SlideShare a Scribd company logo
1 of 78
IN PROCESS QUALITY 
CONTROL OF 
SUSPENSIONS AND 
EMULSIONS
CONTENTS 
 IN PROCESS QUALITY CONTROL 
 OBJECTIVE 
 IMPORTANCE 
 USFDA -CGMP GUIDELINES 
 DOCUMENTATION 
 IPQC OF SUSPENSIONS 
 IPQC OF EMULSIONS 
 COMLETION STAGE 
 RECORD&REPORT 
 PACKAGING MATERIALS CONTROL 
 LABELS CONTROL 
 CONCLUSION
IN PROCESS QUALITY CONTROL 
 IPQC means controlling the procedures 
involved in manufacturing of the dosage form 
starting from raw material purchase to 
dispatch of the quality product in ideal 
packaging. 
 It monitors all the features of the product 
that may affect its quality and prevent errors 
during processing. 
 It is the activity performed between QA&QC.
OBJECTIVE 
 The primary objective of the system is to 
monitor all the features of o product that may 
affect its quality and to prevent error during 
processing. 
 The in process checking during manufacturing 
plays an important role in the auditing of the 
product at various stages of production. 
 They are used to detect variation from the 
tolerance limits of the product so that promote 
and corrective actions can be taken.
PURPOSE 
 To ensure detectable and significant human 
errors. 
 To minimize inter batch and intra batch 
variability. 
 To ensure quality of final product. 
 To ensure continuous monitoring of process 
variables which are going to affect the quality 
of product.
IMPORTANCE 
 Provide accurate,specific and definite 
description of the procedure to be employed. 
 It is a planned system to identify the 
materials,equipment, processes, and 
operators. 
 It is to detect the errors if and when it does 
occurs. 
 Is to enforce the flow of manufacturing and 
packing operation according to established 
rules and practice.
For proper function of IPQC 
the following must be 
defined 
 Number of samples to be taken for analysis 
and frequency of sampling. 
 Quantitative amounts of each sample. 
 Allowable variability. 
 Which process is to be monitored and at what 
phase.
USFDA-CGMP guidelines 
 To assure batch uniformity and integrity of 
drug product,written procedures shall be 
established and followed. 
 Valid in process specification for such 
characteristics shall be constituent with drug 
product. 
 In process material shall be tested for 
identity,strength,quality and purity.
IPQC TESTS 
 These are the tests performed between 
QA&QC and provides for the organization of 
approved raw materials for manufacturing 
based on actual laboratory testing generally 
called as IPQC tests such as 
physical,chemical,microbiologic and biologic 
tests.
TYPES OF IPQC TESTS 
 IPQC TESTS ARE TWO TYPES 
 1)Physical and chemical tests 
 a)Identity test 
 b)quality test 
 c)purity test 
 d)potency test 
 2)Biologic and microbiologic tests
Documentation 
 Recording the operations in a written form is 
documentation. 
 If it was not documented,it was not done 
describes the linkage between written 
records of action taken and the quality 
operation.
Master formula record 
 The name of the product,dosage form and its 
strength. 
 The complete list of ingredients. 
 The quantity by weight or volume of each 
ingredient. 
 The standards or specifications of each ingredient 
used in the product. 
 An appropriate statement concerning any calculated 
excess of an ingredient. 
 Appropriate statements of theoretic yield at various 
stages and the termination of processing.
 Manufacturing and control 
instructions,specifications,precautions and 
special notations to be followed. 
 A detailed description of the 
closures,containers,labelling,packaging,and 
other finishing materials.
Areas controlled by IPQC 
 Manufacturing area 
 Packaging area 
 Manufacturing area 
General cleanliness 
RH/temperature 
Status label present for 
a)all tanks 
b)jacketed vessels 
c)other manufacturing accessories 
Raw materials other than that current batch removed 
All tanks properly covered
Packaging area 
 General cleanliness 
 Status label present for 
a)Packaging/filling area 
b)Filling machine 
c)cap sealing machine 
 Packaging materials other than that required for 
current batch required 
 Bottle washing 
 Filling tanks 
 Leak test 
 Check on filled bottles 
 Coding details 
 Labelling 
 Carton
SUSPENSIONS 
 Pharmaceutical suspensions may be defined 
as coarse dispersions in which insoluble solids 
are suspended in a liquid medium. 
 The liquid medium is usually water or a water 
based vehicle. 
 The insoluble solid may have size range from 
10 to 1000 μm. 
 Suspensions are also called heterogeneous 
systems,or more precisely biphasic systems.
Classification 
 1)Based on proportion of solid particles 
a)Dilute suspensions(2 to 10% w/v solid) 
b)concentrated suspensions(50% w/v solid) 
 2)Based on electrokinetic properties of 
solid particles 
a)flocculated suspensions 
b)deflocculated suspensions 
 3)Based on general classes 
a)oral suspensions 
b)externally applied suspensions 
c)parenteral suspensions
IPQC TESTS OF SUSPENSIONS 
 Appearance 
 Photo microscopic examination 
 Color,odor and taste 
 Density 
 pH value 
 Clarity testing 
 Pourability 
 Viscosity 
 Rheology
 Zeta potential measurement 
 Drug content uniformity 
 Particle size measurement 
 Sedimentation rate and sedimentation 
volume 
 Redispersibility 
 Potency test 
 Preservative effectiveness 
 Compatibility with primary container-closure 
system
Appearance 
 The appearance in a graduated glass cylinder 
or transparent glass container is noted.It is 
checked for 
 Uniformity of color and appearance of the 
sediment 
 Any breaks or air pockets in the sediment 
 Any coagulated material adhering to the 
inside wall of the container.
Photo microscopic 
examination 
 The microscope can be used to estimate and 
detect changes in particle size distribution 
and crystal shape.Its usefulness can be 
enhanced by attaching a polaroid type 
camera to the microscope to permit rapid 
processing of photomicrographs. 
 This can be used to distinguish between 
flocculated and non-flocculated particles and 
to determine changes in the physical 
properties.
Color,odor and taste 
 These characteristics are especially important 
in orally administered suspensions.Variation 
in color often indicates poor distribution 
and/or differences in particle size.Variation in 
taste,especially of active constituents can 
often be attributed to changes in particle 
size,crystal habit and subsequent particle 
dissolution. 
 Changes in color,odor and taste can also 
indicates chemical instability.
Density 
 Specific gravity or density of the suspension 
is an important parameter. Decrease in 
density indicates the presence of entrapped 
air with in the structure of the suspension. 
 Density measurements at a given 
temperature should be made using well-mixed 
uniform suspension. 
 Hydrometers are used to measure the 
density.
pH value 
 pH of the phases of suspension also contribute to 
stability and characteristics of formulations.So 
pH of the different vehicles,phases of suspension 
before mixing and after mixing are monitored 
and recorded time to time to ensure optimum 
pH environment being maintained. 
 Different types of methods are used in the 
measurement of pH. 
 a)Dip a piece of pH paper into the sample. 
 b)pH meter
Clarity testing 
 Clarity testing is carried out to check the 
particulate matter in the sample.
Pourability 
 This test is carried out on the phases of 
suspension after mixing to ensure that the 
final preparation is pourable and will not 
cause any problem during filling and during 
handling by patient
viscosity 
 Stability of a suspension is solely dependant on the 
sedimentation rate of dispersed phase which is 
dependant on the viscosity of the dispersion 
medium.So this test is carried out to ensure 
optimum viscosity of the medium so a 
stable,redispersible suspension can be formed. 
 The viscosity of the dispersion medium is measured 
before mixing with dispersed phase and also 
viscosity after mixing is determined using Brook 
field viscometer. 
 The calculated values are compared with standard 
values and if any difference is found necessary 
corrective action is taken to get optimized viscosity.
Viscosity measurement 
 In suspensions the flow properties have 
profound influence in the manufacture,during 
storage and administration of drugs.The flow 
properties depends on the viscosity of the 
suspension. 
 The viscosity can be measured by 
 a)cup and bob viscometer(destructive 
method) 
 b)cone and plate viscometer(destructive 
method)
Cup and bob viscometer 
 The sample is placed in the cup and the bob is placed 
in the cup up to an appropriate height. 
 The sample is accommodated between the gap of 
cup and bob. 
 Either the cup or bob is made to rotate and the 
torque resulting from the viscous drag is measured 
by a spring or sensor in the drive of the bob. 
 The number of revolutions and the torque represent 
the rate of shear and shearing stress respectively. 
 ή=kw/v 
 ή=apparent viscosity w=shearing stress 
 v=rpm(shear rate) k=instrument constant
Cone and plate viscometer 
 The sample is placed at the centre of the plate which is then 
raised into a position under the cone. 
 The cone is driven by a variable-speed motor and the 
sample is sheared in the narrow gap between the stationary 
plate and the rotating cone. 
 The rate of shear in rpm is increased or decreased by a 
selector dial and the viscous traction or torque(shear stress) 
produced on the cone is read on the indicator scale. 
ή=cT/v 
 c=instrument constant T=shearing stress 
 v=shear rate ή=viscosity
Rheology 
 Rheology is the science that concerns with the flow of 
liquids and the deformation of solids. 
 Brookfield viscometer is used to evaluate the rheological 
properties and behaviour of settling of suspensions. 
 Brookfield viscometer mounted on helipath stand with T 
spindle. 
 The T bar rotates and descends slowly into the suspension 
with the help of synchronous motor. 
 The path traced by the spindle is a helix.As the T bar moves 
the sediment offers resistance. 
 The dial reading indicates the magnitude of resistance. 
 The dial reading is plotted against the number of turns of 
the spindle. 
 Good suspensions show a lesser rate of increase of dial 
reading as the spindle turns that is the curve is horizontal 
for a longer period.
Zeta potential measurement 
 Zeta potential is defined as the difference in 
potential between the surface of the tightly 
bound layer(shear plane) and electro-neutral 
region of the solution. 
 Zeta potential has practical application in 
stability of systems containing dispersed 
particles since this potential governs the degree 
of repulsion between the adjacent similarly 
charged dispersed particles. 
 Value of zeta potential reflects the future 
stability of suspension so it is monitored time to 
time to ensure optimum zeta potential. 
 The flocculated suspension is one in which zeta 
potential of particle is -20 to +20 mv.
 Zeta potential can be measured by 
 a)zeta meter 
 b)micro-electrophoresis 
 Electrophoresis 
 The principle of electrophoresis is used to 
determine the sign and magnitude of zeta 
potential. 
 Electrophoresis involves the movement of a 
charged particle through a liquid under the 
influence of an applied potential difference. 
 An electrophoresis cell is fitted with two 
electrodes. 
 The dispersion is introduced into the cell.when a 
potential is applied across the electrodes,particles 
migrate towards oppositely charged electrodes. 
 The rate of migration is a function of the charge on 
a particle.
 As the potential gradient across the 
electrodes increases the velocity of migration 
of particles increases. 
 Velocity of migration potential gradient 
of particles (cm/sec) α across the electrodes 
v α E 
v=ζE 
There are number of factors that influence 
the migration so the zeta potential can be 
calculated by 
ζ = v4πή 
Eє
Drug content uniformity 
 For proper dosing of the dosage form it is 
necessary that the active ingredient is 
uniformly distributed throughout the dosage 
form.so samples are withdrawn from the 
dispersed phase after micronization and after 
mixing with dispersion medium,assayed to 
find out degree of homogeneity. 
 If any discrepancy is found out it is suitably 
corrected by monitoring the mixing step to 
ensure a reliable dosage formulation.
Particle size of dispersed 
phase 
 Optimum size of drug particle in the 
dispersed phase plays a vital role in stability 
of final suspension. 
 So this test is carried out to microscopically 
analyse and find out particle size range of 
drug then it is compared with optimum 
particle size required. 
 If any difference is found,stricter monitoring 
of micronization step is ensured.
Particle size measurement 
 Particle size can be measured by 
 a)optical microscopy 
 b)sedimentation method 
 c)conductivity method(coulter counter 
method)
Optical microscopy 
 Particle size in the range of 0.2 to 100μm can be measured by 
optical microscopy. 
 This method directly gives number distribution. 
 Method:Eye piece of the microscope is fitted with a micrometer. 
 The eye-piece micrometer is calibrated using a standard stage 
micrometer. 
 The sample of suspension is mounted on a slide or a ruled cell 
and placed it on the mechanical stage. 
 The size of the particle is estimated with the help of the eye-piece 
micrometer. 
 Around 625 particles must be counted in order to estimate the 
true mean. 
 The size frequency distribution curve is plotted by taking particle 
size in μm on x-axis and frequency on y-axis.
Sedimentation method 
 Sedimentation method may be used over a size 
range of 1 to 200μm. 
 Sedimentation of particles are evaluated by 
 a)Andreasen pipette method 
 b)Balance method 
 c)Hydrometer method 
 In this methods the particle size is expressed as 
Stokes diameter.
Andreasen pipette method 
 Andreasen apparatus consists of a 550 ml cylindrical 
vessel containing a 10 ml pipette sealed to a ground 
glass stopper. 
 When the pipette is placed in the cylinder its lower 
tip is 20 cm below the surface of the suspension. 
 Transfer the suspension into the Andreasen vessel 
and place the two-way pipette and securely suspend 
the vessel in a constant temperature water bath. 
 At different time intervals 10 ml of samples are 
withdrawn using two-way stopcock and collected in 
watch-glass,evaporated and weighed. 
 Particle diameter is calculated from stokes law.
Andreasen apparatus
Sedimentation 
 An ideal suspension can be prepared by 
preventing the settling of particles. 
 The settling of particles can be explained by 
theories related to sedimentation. 
a)theory of Brownian movement 
b)theory of sedimentation 
 These theories provides information regarding 
factors that affect the settling of solids,these 
factors enable to take appropriate action in the 
manufacture of suspension.
Theory of Brownian movement 
 Brownian movement of particles prevents 
sedimentation. 
 Brownian movement can be observed,if the 
size of the particle is about 2 to 5μm,provided 
densities of the particles and viscosity of the 
medium are favourable. 
 Theory of Brownian movement proposes 
particle size and viscosity as the major 
factors.
Sedimentation rate 
 The rate of sedimentation of particles is expressed 
by Stokes law 2 
d (Þ1-Þ2)g 
 rate of sedimentation= 18ή 
d=diameter of the particle(cm) 
Þ1=density of the dispersed phase(g/ml) 
Þ2=density of the dispersion medium(gm/ml) 
ή=viscosity of the dispersion medium(poise) 
g=acceleration due to gravity(980.7cm/sec)
 Stokes law is useful in fixing factors to prevent 
sedimentation. 
 Particle size:If the particle size is reduced to half 
of itsoriginal size the rate of sedimentation 
decreases by a factor of four. 
 Viscosity of medium:The viscosity of suspension 
should be optimum. 
 Density of the medium:The density of medium 
should be high so that the difference in densities 
will be minimal. 
 The density of medium can be increased by 
including ingredients such as 
polyvinylpyrrolidine,sugars,polyethyleneglycols, 
glycerin etc.
Sedimentation volume 
 It is the ratio between ultimate volume of 
sediment to initial volume of the suspension. 
F=Vu/V0=ultimate volume of the sediment 
initial volume of the suspension 
when a measuring cylinder is used to measure 
the volume it can be written as Hu/H0 
The F value is between the limits 0 to 1. 
The higher the sedimentation volume the 
better is the physical stability.
Sedimentation volume
Redispersibility 
 If the particles settle they should be easily 
redispersible by a moderate amount of 
shaking.
EMULSIONS 
 Emulsion systems consisting of at least two 
immiscible liquid phases,one of which is 
dispersed as small globules in the other liquid 
phase. 
 The globule diameter may range from 0.1 to 
100 μm. 
 Emulsions are thermodynamically unstable 
systems. 
 Emulsions are also called as heterogeneous 
systems ,or more precisely biphasic systems.
classification 
 1)Based on nature of dispersed phase 
a)oil-in-water(o/w) 
b)water-in-oil(w/o) 
 2)Based on the globule size 
a)micro emulsions(0.01μm) 
b)fine emulsions(0.25 to 25μm)
Instability of emulsions
Flocculation 
 Neighbouring globules come closer to each 
other and form colonies in the external 
phase. 
 This is the initial stage that leads to instability 
 The extent of flocculation of globules 
depends on 
 a)globule size distribution 
 b)charge on globule surface 
 c)viscosity of external medium
Creaming 
 Creaming is the concentration of globules at the 
top or bottom of the emulsion. 
 The floccules move either upward or downward 
leading to creaming. 
 It can be observed by a difference in colour shade 
of the layers. 
 Creaming is influenced by 
 a)globule size 
 b)viscosity of the dispersion medium 
 c)differences in the densities of dispersed phase 
and dispersion medium
Coalescence 
 Coalescence is followed by creaming stage. 
 In this process the emulsifier film around the 
globules is destroyed to a certain extent. 
 This step can be recognised by increased globule 
size and reduced number of globules. 
 Coalescence is observed due to 
a)insufficient amount of the emulsifying agent 
b)altered partitioning of the emulsifying agent 
c)incompatibilities between emulsifying agents
Breaking 
 This is indicated by complete separation of oil 
and aqueous phases. 
 It is an irreversible process that is simple 
mixing fails to resuspend the globules into an 
uniform emulsion. 
 In breaking the protective sheath around the 
globules is completely destroyed.
Phase inversion 
 This involves the change of emulsion type 
from o/w to w/o or vice versa. 
 When we intend to prepare one type of 
emulsion say o/w and if the final emulsion 
turns out to be w/o it can be termed as a sign 
of instability
IPQC tests for emulsions 
 Appearance 
 Clarity testing 
 pH value 
 Viscosity 
 Rheology 
 Drug content uniformity 
 Particle size distribution 
 Densities of phases
 Phase volume ratio 
 Charge of electrical double layer 
 Physical properties of interface 
 Temperature fluctuations 
 Quality control of water 
 Breaking or cracking 
 Compatibility of product with container-closure 
system
viscosity 
 As the viscosity increases flocculation of 
globules will be reduced .simultaneously the 
Brownian movement of globules will also be 
hindered leading to creaming. 
 Due to this antagonistic effect an optimum 
viscosity is desirable for good stability. 
 Viscosity can be measured by 
 a)cop and bob viscometer 
 b)cone and plate viscometer
Particle size 
 As the globule size is reduced they tend to 
exhibit Brownian movement. 
 According to stokes law the diameter of the 
globule is considered as a major factor in 
creaming of emulsion.The rate of creaming 
decreases four folds when the globule 
diameter is halved. 
 So it is necessary to choose the optimum 
globule size for maximum stability.
Particle size distribution 
 Globules of uniform size impart maximum 
stability. 
 In such emulsions globules pack loosely and 
globule to globule contact is less. 
 Globule distribution is effected by 
viscosity,phase volume ratio,density of 
phases etc. 
 An optimum degree of size distribution range 
should be choosen to achieve maximum 
physical stability.
Globule size determination 
 Microscopic examination of globule size 
distribution analysis is an useful tool to 
evaluate the physical stability.
Phase volume ratio 
 In an emulsion the relative volume of water to oil is 
expressed as phase volume ratio. 
 In general most medicinal emulsions are prepared 
with a volume ratio of 50:50.This proportion brings 
about loose packing of globules. 
 The upper limit 74% of oil can be incorporated in an 
emulsion but this may lead to breaking of the 
emulsion.This value is referred to as critical point of 
phase volume ratio. 
 Critical point is defined as the concentration of 
internal phase above which the emulsifying agent 
cannot produce a stable emulsion of the desired 
type.
Extent of phase separation 
. 
 The practical and commercial aspect of 
stability is the study of phase separation. 
 This is quick method and can be applied for 
poorly formed and rapidly breaking 
emulsions. 
 Separation of phases is visible after a definite 
period of time,though the signs of instability 
begin quite early.
Charge of electrical double 
layer 
 When ionic type of emulsifier is employed, 
the electrical double layer(interface between 
oil and water)possesses charge. 
 The repulsive forces,due to like charges on 
the surface of the globules prevent the 
flocculation of globules.
Physical properties of 
interface 
 The interfacial film of the emulsifier is responsible 
for enhancing the stability of the product. 
 The film should be elastic enough to form rapidly as 
soon as droplets are produced.This behaviour 
facilitates the production of emulsion. 
 Similarly on moderate shaking the emulsion should 
be reconstituted. 
 After manufacture the film should be tough so that 
coalescence of globules can be prevented. 
 So suitable emulsifying agents such as surfactants 
should be selected to achieve the above film 
properties at the interface.
Densities of phases 
 By adjusting the density of the phases to the 
same value we can increase the stability of 
emulsion. 
 Oil phase density can be enhanced by adding 
brominated oil when the oil is an external 
phase.
Temperature fluctuations 
 Elevated temperatures alter the partition 
characteristics of the emulsifiers and 
preservatives results in instability. 
 Temperature also enhances the chemical 
degradation of drugs and other ingredients. 
 At lower temperature the aqueous phase may 
contain ice crystals which rupture the interfacial 
film and break the emulsion. 
 So care should be taken to prevent temperature 
fluctuations during manufacture and storage.
Phase inversion 
 The emulsion is checked for phase inversion. 
 Phase inversion means a change of emulsion 
type from o/w to w/o or vice versa.
Completion stage 
 At the completion of manufacturing process 
as well as in-process stages,actual yields are 
checked against theoretic value and the repre 
sentative sample are withdrawn for 
laboratory testing by the control inspector 
according to the predetermined sampling 
plan.
Record and report 
 The batch production records and other 
needed documents are then delivered to the 
quality control office together with the 
withdrawn samples of the products.
Packaging material control 
 Packaging material should not interact 
physically or chemically with the finished 
product to alter the strength,quality or purity 
beyond specified requirements. 
 The following features are to be considered in 
developing container specifications 
 Properties of container tightness 
 Moisture and vapour tightness regardless of 
container construction 
 Compatibility between container and product
 Toxicity and chemical/physical characteristics 
of materials needed in container 
construction. 
 Physical or chemical changes of container 
upon prolonged contact with product.
Labels control 
 Production control issues a packaging form that 
carries 
 The name of the product 
 Item number 
 Lot number 
 Number of labels 
 Inserts 
 Packaging material to be used 
 Operation to be performed 
 Quantity to be packaged 
 A copy of this is sent to the supervisor of label control,who 
in turn counts out the required number of labels.
conclusion 
 IPQC tests are carried out during the 
manufacturing to ensure stable,safe and 
quality product.
References 
 Lachman L,Lieberman H,The Theory and 
Practice of Industrial pharmacy;3rd 
edition,page number-810 to 835. 
 C.V.S.Subrahmanyam,Text book of Physical 
Pharmaceutics,page number-195 to 203,366 
to 423. 
 Encyclopedia volume-6 page number 3105- 
3107.
THANK YOU

More Related Content

What's hot

Ipqc tests for tablet
Ipqc tests for tabletIpqc tests for tablet
Ipqc tests for tabletMalay Jivani
 
Inprocess as per usp ip bp tablets
Inprocess as per usp ip bp tabletsInprocess as per usp ip bp tablets
Inprocess as per usp ip bp tabletsDeepak Jain
 
Ipqc and fpqc test for suppositories
Ipqc and fpqc test for suppositoriesIpqc and fpqc test for suppositories
Ipqc and fpqc test for suppositoriesArpitSuralkar
 
Disintegration and dissolution tests
Disintegration and dissolution testsDisintegration and dissolution tests
Disintegration and dissolution testsAmera Abdelelah
 
IPQC and FPQC for tablets
IPQC and FPQC for tabletsIPQC and FPQC for tablets
IPQC and FPQC for tabletsMukesh Patil
 
pharmacopoeial standards for tablet
pharmacopoeial standards for tablet pharmacopoeial standards for tablet
pharmacopoeial standards for tablet Rohit K.
 
Quality control test for powders
Quality control test for powdersQuality control test for powders
Quality control test for powdersParimala Gattupalli
 
Stability of packaging in pharmacy
Stability of packaging in pharmacyStability of packaging in pharmacy
Stability of packaging in pharmacyRahul Pandit
 
Ipqc for parenterals
Ipqc for parenteralsIpqc for parenterals
Ipqc for parenteralsceutics1315
 
Manufacturing Flow Chart And IPQC Test Of SUSPENSION
Manufacturing Flow Chart And IPQC Test Of SUSPENSIONManufacturing Flow Chart And IPQC Test Of SUSPENSION
Manufacturing Flow Chart And IPQC Test Of SUSPENSIONAditi Roy
 
Quality control tests for liquid orals and gels
Quality control tests for liquid orals and gelsQuality control tests for liquid orals and gels
Quality control tests for liquid orals and gelsSandhya Chintalacheruvu
 
Quality control test for packaging material ,qc test for glass,metal,rubber
Quality control test for packaging material ,qc test for glass,metal,rubberQuality control test for packaging material ,qc test for glass,metal,rubber
Quality control test for packaging material ,qc test for glass,metal,rubberKunalPatel257
 
In Process Quality Control Tests (IPQC) for Solid Dosage From
In Process Quality Control Tests (IPQC) for Solid Dosage FromIn Process Quality Control Tests (IPQC) for Solid Dosage From
In Process Quality Control Tests (IPQC) for Solid Dosage FromSagar Savale
 
Quality control of suppositories
Quality control of suppositoriesQuality control of suppositories
Quality control of suppositoriesDR RAMSHA TAREEN
 
CMA-CPP-CQA for oral solid dosageform
CMA-CPP-CQA for oral solid dosageformCMA-CPP-CQA for oral solid dosageform
CMA-CPP-CQA for oral solid dosageformGuru Balaji .S
 
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)Gaurav kumar
 
Process Validation of Liquid Orals
Process Validation of Liquid OralsProcess Validation of Liquid Orals
Process Validation of Liquid OralsAasawaree Yadav
 
Quality control test: Containers, Closures and Secondary packing materials
Quality control test: Containers, Closures and  Secondary packing materialsQuality control test: Containers, Closures and  Secondary packing materials
Quality control test: Containers, Closures and Secondary packing materialsPranali Polshettiwar
 

What's hot (20)

Ipqc tests for tablet
Ipqc tests for tabletIpqc tests for tablet
Ipqc tests for tablet
 
Inprocess as per usp ip bp tablets
Inprocess as per usp ip bp tabletsInprocess as per usp ip bp tablets
Inprocess as per usp ip bp tablets
 
Ipqc and fpqc test for suppositories
Ipqc and fpqc test for suppositoriesIpqc and fpqc test for suppositories
Ipqc and fpqc test for suppositories
 
Disintegration and dissolution tests
Disintegration and dissolution testsDisintegration and dissolution tests
Disintegration and dissolution tests
 
IPQC and FPQC for tablets
IPQC and FPQC for tabletsIPQC and FPQC for tablets
IPQC and FPQC for tablets
 
pharmacopoeial standards for tablet
pharmacopoeial standards for tablet pharmacopoeial standards for tablet
pharmacopoeial standards for tablet
 
Quality control test for powders
Quality control test for powdersQuality control test for powders
Quality control test for powders
 
Stability of packaging in pharmacy
Stability of packaging in pharmacyStability of packaging in pharmacy
Stability of packaging in pharmacy
 
Ipqc for parenterals
Ipqc for parenteralsIpqc for parenterals
Ipqc for parenterals
 
Inprocess quality control of emulsions
Inprocess quality control of emulsionsInprocess quality control of emulsions
Inprocess quality control of emulsions
 
Manufacturing Flow Chart And IPQC Test Of SUSPENSION
Manufacturing Flow Chart And IPQC Test Of SUSPENSIONManufacturing Flow Chart And IPQC Test Of SUSPENSION
Manufacturing Flow Chart And IPQC Test Of SUSPENSION
 
Preformulation
PreformulationPreformulation
Preformulation
 
Quality control tests for liquid orals and gels
Quality control tests for liquid orals and gelsQuality control tests for liquid orals and gels
Quality control tests for liquid orals and gels
 
Quality control test for packaging material ,qc test for glass,metal,rubber
Quality control test for packaging material ,qc test for glass,metal,rubberQuality control test for packaging material ,qc test for glass,metal,rubber
Quality control test for packaging material ,qc test for glass,metal,rubber
 
In Process Quality Control Tests (IPQC) for Solid Dosage From
In Process Quality Control Tests (IPQC) for Solid Dosage FromIn Process Quality Control Tests (IPQC) for Solid Dosage From
In Process Quality Control Tests (IPQC) for Solid Dosage From
 
Quality control of suppositories
Quality control of suppositoriesQuality control of suppositories
Quality control of suppositories
 
CMA-CPP-CQA for oral solid dosageform
CMA-CPP-CQA for oral solid dosageformCMA-CPP-CQA for oral solid dosageform
CMA-CPP-CQA for oral solid dosageform
 
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)
In Process Quality Control System (IPQC) for Solid Dosages Form (Tablets)
 
Process Validation of Liquid Orals
Process Validation of Liquid OralsProcess Validation of Liquid Orals
Process Validation of Liquid Orals
 
Quality control test: Containers, Closures and Secondary packing materials
Quality control test: Containers, Closures and  Secondary packing materialsQuality control test: Containers, Closures and  Secondary packing materials
Quality control test: Containers, Closures and Secondary packing materials
 

Similar to In process quality control of suspensions and emulsions

Process validation of capsules
Process validation of capsulesProcess validation of capsules
Process validation of capsulespritam kumbhar
 
Process validation- This guidance incorporates principles and approaches that...
Process validation- This guidance incorporates principles and approaches that...Process validation- This guidance incorporates principles and approaches that...
Process validation- This guidance incorporates principles and approaches that...Sanchit Dhankhar
 
PROCESS VALIDATION OF AN OINMENT AND LIQUID ORALS
PROCESS VALIDATION OF AN OINMENT AND LIQUID ORALSPROCESS VALIDATION OF AN OINMENT AND LIQUID ORALS
PROCESS VALIDATION OF AN OINMENT AND LIQUID ORALSNeetuVishwakarma13
 
Process validation fof Pharmaceutical dosage forms (formulation)
Process validation fof Pharmaceutical dosage forms (formulation)Process validation fof Pharmaceutical dosage forms (formulation)
Process validation fof Pharmaceutical dosage forms (formulation)MD NOUSHAD JAVED
 
In Process Quality Control (IPQC) of pharmaceutical dosage form in Pharmaceut...
In Process Quality Control (IPQC) of pharmaceutical dosage form in Pharmaceut...In Process Quality Control (IPQC) of pharmaceutical dosage form in Pharmaceut...
In Process Quality Control (IPQC) of pharmaceutical dosage form in Pharmaceut...Saad Ahmed Sami
 
PROCESS VALIDATION OF INJECTABLES
PROCESS VALIDATION OF INJECTABLESPROCESS VALIDATION OF INJECTABLES
PROCESS VALIDATION OF INJECTABLESKhushboo Pasbola
 
validation of tablet and capsule formulation8
validation of tablet and capsule formulation8validation of tablet and capsule formulation8
validation of tablet and capsule formulation8tanvikumbhar
 
IPQC of Pharmaceutical Dosage Form at Pharmaceutical Industry
IPQC of Pharmaceutical Dosage Form at Pharmaceutical Industry  IPQC of Pharmaceutical Dosage Form at Pharmaceutical Industry
IPQC of Pharmaceutical Dosage Form at Pharmaceutical Industry mahbub tanim
 
IPQC of dosage form in pharmaceutical industry
IPQC of dosage form in pharmaceutical industryIPQC of dosage form in pharmaceutical industry
IPQC of dosage form in pharmaceutical industryKay kay shain marma
 
Product validation
Product  validationProduct  validation
Product validationsuhasini
 
Ipqc 112070804017
Ipqc 112070804017Ipqc 112070804017
Ipqc 112070804017Patel Parth
 
Validation m pharmacy notes scop satara
Validation m pharmacy notes scop sataraValidation m pharmacy notes scop satara
Validation m pharmacy notes scop sataranikhil salunkhe
 
Dissolution chapter
Dissolution chapter Dissolution chapter
Dissolution chapter Arshad Khan
 

Similar to In process quality control of suspensions and emulsions (20)

Qa and qc seminar
Qa and qc seminarQa and qc seminar
Qa and qc seminar
 
Process validation of capsules
Process validation of capsulesProcess validation of capsules
Process validation of capsules
 
Process validation- This guidance incorporates principles and approaches that...
Process validation- This guidance incorporates principles and approaches that...Process validation- This guidance incorporates principles and approaches that...
Process validation- This guidance incorporates principles and approaches that...
 
Process validation Ointment Cream LIquid Oral
Process validation Ointment Cream LIquid OralProcess validation Ointment Cream LIquid Oral
Process validation Ointment Cream LIquid Oral
 
PROCESS VALIDATION OF AN OINMENT AND LIQUID ORALS
PROCESS VALIDATION OF AN OINMENT AND LIQUID ORALSPROCESS VALIDATION OF AN OINMENT AND LIQUID ORALS
PROCESS VALIDATION OF AN OINMENT AND LIQUID ORALS
 
Line clearance ppt
Line clearance pptLine clearance ppt
Line clearance ppt
 
Process validation fof Pharmaceutical dosage forms (formulation)
Process validation fof Pharmaceutical dosage forms (formulation)Process validation fof Pharmaceutical dosage forms (formulation)
Process validation fof Pharmaceutical dosage forms (formulation)
 
In Process Quality Control (IPQC) of pharmaceutical dosage form in Pharmaceut...
In Process Quality Control (IPQC) of pharmaceutical dosage form in Pharmaceut...In Process Quality Control (IPQC) of pharmaceutical dosage form in Pharmaceut...
In Process Quality Control (IPQC) of pharmaceutical dosage form in Pharmaceut...
 
PROCESS VALIDATION OF INJECTABLES
PROCESS VALIDATION OF INJECTABLESPROCESS VALIDATION OF INJECTABLES
PROCESS VALIDATION OF INJECTABLES
 
validation of tablet and capsule formulation8
validation of tablet and capsule formulation8validation of tablet and capsule formulation8
validation of tablet and capsule formulation8
 
IPQC of Pharmaceutical Dosage Form at Pharmaceutical Industry
IPQC of Pharmaceutical Dosage Form at Pharmaceutical Industry  IPQC of Pharmaceutical Dosage Form at Pharmaceutical Industry
IPQC of Pharmaceutical Dosage Form at Pharmaceutical Industry
 
Ipqc presentation
Ipqc presentationIpqc presentation
Ipqc presentation
 
VEDIKA-1.pptx
VEDIKA-1.pptxVEDIKA-1.pptx
VEDIKA-1.pptx
 
Process validation
Process validationProcess validation
Process validation
 
IPQC of dosage form in pharmaceutical industry
IPQC of dosage form in pharmaceutical industryIPQC of dosage form in pharmaceutical industry
IPQC of dosage form in pharmaceutical industry
 
Product validation
Product  validationProduct  validation
Product validation
 
Ipqc 112070804017
Ipqc 112070804017Ipqc 112070804017
Ipqc 112070804017
 
Process validation of capsule
Process validation of capsuleProcess validation of capsule
Process validation of capsule
 
Validation m pharmacy notes scop satara
Validation m pharmacy notes scop sataraValidation m pharmacy notes scop satara
Validation m pharmacy notes scop satara
 
Dissolution chapter
Dissolution chapter Dissolution chapter
Dissolution chapter
 

More from ceutics1315

Water treatment process by RO UF
Water treatment process by RO UFWater treatment process by RO UF
Water treatment process by RO UFceutics1315
 
Water treatment by demineralisation
Water treatment by demineralisationWater treatment by demineralisation
Water treatment by demineralisationceutics1315
 
Validation of water supply system
Validation of water supply systemValidation of water supply system
Validation of water supply systemceutics1315
 
I R spectroscopy
I R spectroscopyI R spectroscopy
I R spectroscopyceutics1315
 
Thermal analysis
Thermal analysisThermal analysis
Thermal analysisceutics1315
 
Testing the degradation of ascorbic acid by tlc
Testing the degradation of ascorbic acid by tlcTesting the degradation of ascorbic acid by tlc
Testing the degradation of ascorbic acid by tlcceutics1315
 
Super critical fluid chromatography
Super critical fluid chromatographySuper critical fluid chromatography
Super critical fluid chromatographyceutics1315
 
Statisticalqualitycontrol
StatisticalqualitycontrolStatisticalqualitycontrol
Statisticalqualitycontrolceutics1315
 
Small scale and large scale capsule filling machine
Small scale and large scale capsule filling machineSmall scale and large scale capsule filling machine
Small scale and large scale capsule filling machineceutics1315
 
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct
Quality assuranceandregulatorycomplianceforpharmaceuticalproductQuality assuranceandregulatorycomplianceforpharmaceuticalproduct
Quality assuranceandregulatorycomplianceforpharmaceuticalproductceutics1315
 
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct(4)
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct(4)Quality assuranceandregulatorycomplianceforpharmaceuticalproduct(4)
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct(4)ceutics1315
 
Presentation1rohitha reddy
Presentation1rohitha reddyPresentation1rohitha reddy
Presentation1rohitha reddyceutics1315
 
Preformulation en
Preformulation enPreformulation en
Preformulation enceutics1315
 

More from ceutics1315 (20)

Water treatment process by RO UF
Water treatment process by RO UFWater treatment process by RO UF
Water treatment process by RO UF
 
Water treatment by demineralisation
Water treatment by demineralisationWater treatment by demineralisation
Water treatment by demineralisation
 
Validation of water supply system
Validation of water supply systemValidation of water supply system
Validation of water supply system
 
I R spectroscopy
I R spectroscopyI R spectroscopy
I R spectroscopy
 
Thermal analysis
Thermal analysisThermal analysis
Thermal analysis
 
Theories
TheoriesTheories
Theories
 
Testing the degradation of ascorbic acid by tlc
Testing the degradation of ascorbic acid by tlcTesting the degradation of ascorbic acid by tlc
Testing the degradation of ascorbic acid by tlc
 
Tabletcoating
TabletcoatingTabletcoating
Tabletcoating
 
Super critical fluid chromatography
Super critical fluid chromatographySuper critical fluid chromatography
Super critical fluid chromatography
 
Statisticalqualitycontrol
StatisticalqualitycontrolStatisticalqualitycontrol
Statisticalqualitycontrol
 
Small scale and large scale capsule filling machine
Small scale and large scale capsule filling machineSmall scale and large scale capsule filling machine
Small scale and large scale capsule filling machine
 
Shivaoo1
Shivaoo1Shivaoo1
Shivaoo1
 
Saivani ppt
Saivani pptSaivani ppt
Saivani ppt
 
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct
Quality assuranceandregulatorycomplianceforpharmaceuticalproductQuality assuranceandregulatorycomplianceforpharmaceuticalproduct
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct
 
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct(4)
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct(4)Quality assuranceandregulatorycomplianceforpharmaceuticalproduct(4)
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct(4)
 
Qbd1
Qbd1Qbd1
Qbd1
 
Qaunitv
QaunitvQaunitv
Qaunitv
 
Presentation1rohitha reddy
Presentation1rohitha reddyPresentation1rohitha reddy
Presentation1rohitha reddy
 
Preformulation en
Preformulation enPreformulation en
Preformulation en
 
Pre formulaton
Pre formulatonPre formulaton
Pre formulaton
 

In process quality control of suspensions and emulsions

  • 1. IN PROCESS QUALITY CONTROL OF SUSPENSIONS AND EMULSIONS
  • 2. CONTENTS  IN PROCESS QUALITY CONTROL  OBJECTIVE  IMPORTANCE  USFDA -CGMP GUIDELINES  DOCUMENTATION  IPQC OF SUSPENSIONS  IPQC OF EMULSIONS  COMLETION STAGE  RECORD&REPORT  PACKAGING MATERIALS CONTROL  LABELS CONTROL  CONCLUSION
  • 3. IN PROCESS QUALITY CONTROL  IPQC means controlling the procedures involved in manufacturing of the dosage form starting from raw material purchase to dispatch of the quality product in ideal packaging.  It monitors all the features of the product that may affect its quality and prevent errors during processing.  It is the activity performed between QA&QC.
  • 4. OBJECTIVE  The primary objective of the system is to monitor all the features of o product that may affect its quality and to prevent error during processing.  The in process checking during manufacturing plays an important role in the auditing of the product at various stages of production.  They are used to detect variation from the tolerance limits of the product so that promote and corrective actions can be taken.
  • 5. PURPOSE  To ensure detectable and significant human errors.  To minimize inter batch and intra batch variability.  To ensure quality of final product.  To ensure continuous monitoring of process variables which are going to affect the quality of product.
  • 6. IMPORTANCE  Provide accurate,specific and definite description of the procedure to be employed.  It is a planned system to identify the materials,equipment, processes, and operators.  It is to detect the errors if and when it does occurs.  Is to enforce the flow of manufacturing and packing operation according to established rules and practice.
  • 7. For proper function of IPQC the following must be defined  Number of samples to be taken for analysis and frequency of sampling.  Quantitative amounts of each sample.  Allowable variability.  Which process is to be monitored and at what phase.
  • 8. USFDA-CGMP guidelines  To assure batch uniformity and integrity of drug product,written procedures shall be established and followed.  Valid in process specification for such characteristics shall be constituent with drug product.  In process material shall be tested for identity,strength,quality and purity.
  • 9. IPQC TESTS  These are the tests performed between QA&QC and provides for the organization of approved raw materials for manufacturing based on actual laboratory testing generally called as IPQC tests such as physical,chemical,microbiologic and biologic tests.
  • 10. TYPES OF IPQC TESTS  IPQC TESTS ARE TWO TYPES  1)Physical and chemical tests  a)Identity test  b)quality test  c)purity test  d)potency test  2)Biologic and microbiologic tests
  • 11. Documentation  Recording the operations in a written form is documentation.  If it was not documented,it was not done describes the linkage between written records of action taken and the quality operation.
  • 12. Master formula record  The name of the product,dosage form and its strength.  The complete list of ingredients.  The quantity by weight or volume of each ingredient.  The standards or specifications of each ingredient used in the product.  An appropriate statement concerning any calculated excess of an ingredient.  Appropriate statements of theoretic yield at various stages and the termination of processing.
  • 13.  Manufacturing and control instructions,specifications,precautions and special notations to be followed.  A detailed description of the closures,containers,labelling,packaging,and other finishing materials.
  • 14. Areas controlled by IPQC  Manufacturing area  Packaging area  Manufacturing area General cleanliness RH/temperature Status label present for a)all tanks b)jacketed vessels c)other manufacturing accessories Raw materials other than that current batch removed All tanks properly covered
  • 15. Packaging area  General cleanliness  Status label present for a)Packaging/filling area b)Filling machine c)cap sealing machine  Packaging materials other than that required for current batch required  Bottle washing  Filling tanks  Leak test  Check on filled bottles  Coding details  Labelling  Carton
  • 16. SUSPENSIONS  Pharmaceutical suspensions may be defined as coarse dispersions in which insoluble solids are suspended in a liquid medium.  The liquid medium is usually water or a water based vehicle.  The insoluble solid may have size range from 10 to 1000 μm.  Suspensions are also called heterogeneous systems,or more precisely biphasic systems.
  • 17. Classification  1)Based on proportion of solid particles a)Dilute suspensions(2 to 10% w/v solid) b)concentrated suspensions(50% w/v solid)  2)Based on electrokinetic properties of solid particles a)flocculated suspensions b)deflocculated suspensions  3)Based on general classes a)oral suspensions b)externally applied suspensions c)parenteral suspensions
  • 18. IPQC TESTS OF SUSPENSIONS  Appearance  Photo microscopic examination  Color,odor and taste  Density  pH value  Clarity testing  Pourability  Viscosity  Rheology
  • 19.  Zeta potential measurement  Drug content uniformity  Particle size measurement  Sedimentation rate and sedimentation volume  Redispersibility  Potency test  Preservative effectiveness  Compatibility with primary container-closure system
  • 20. Appearance  The appearance in a graduated glass cylinder or transparent glass container is noted.It is checked for  Uniformity of color and appearance of the sediment  Any breaks or air pockets in the sediment  Any coagulated material adhering to the inside wall of the container.
  • 21. Photo microscopic examination  The microscope can be used to estimate and detect changes in particle size distribution and crystal shape.Its usefulness can be enhanced by attaching a polaroid type camera to the microscope to permit rapid processing of photomicrographs.  This can be used to distinguish between flocculated and non-flocculated particles and to determine changes in the physical properties.
  • 22. Color,odor and taste  These characteristics are especially important in orally administered suspensions.Variation in color often indicates poor distribution and/or differences in particle size.Variation in taste,especially of active constituents can often be attributed to changes in particle size,crystal habit and subsequent particle dissolution.  Changes in color,odor and taste can also indicates chemical instability.
  • 23. Density  Specific gravity or density of the suspension is an important parameter. Decrease in density indicates the presence of entrapped air with in the structure of the suspension.  Density measurements at a given temperature should be made using well-mixed uniform suspension.  Hydrometers are used to measure the density.
  • 24. pH value  pH of the phases of suspension also contribute to stability and characteristics of formulations.So pH of the different vehicles,phases of suspension before mixing and after mixing are monitored and recorded time to time to ensure optimum pH environment being maintained.  Different types of methods are used in the measurement of pH.  a)Dip a piece of pH paper into the sample.  b)pH meter
  • 25. Clarity testing  Clarity testing is carried out to check the particulate matter in the sample.
  • 26. Pourability  This test is carried out on the phases of suspension after mixing to ensure that the final preparation is pourable and will not cause any problem during filling and during handling by patient
  • 27. viscosity  Stability of a suspension is solely dependant on the sedimentation rate of dispersed phase which is dependant on the viscosity of the dispersion medium.So this test is carried out to ensure optimum viscosity of the medium so a stable,redispersible suspension can be formed.  The viscosity of the dispersion medium is measured before mixing with dispersed phase and also viscosity after mixing is determined using Brook field viscometer.  The calculated values are compared with standard values and if any difference is found necessary corrective action is taken to get optimized viscosity.
  • 28. Viscosity measurement  In suspensions the flow properties have profound influence in the manufacture,during storage and administration of drugs.The flow properties depends on the viscosity of the suspension.  The viscosity can be measured by  a)cup and bob viscometer(destructive method)  b)cone and plate viscometer(destructive method)
  • 29. Cup and bob viscometer  The sample is placed in the cup and the bob is placed in the cup up to an appropriate height.  The sample is accommodated between the gap of cup and bob.  Either the cup or bob is made to rotate and the torque resulting from the viscous drag is measured by a spring or sensor in the drive of the bob.  The number of revolutions and the torque represent the rate of shear and shearing stress respectively.  ή=kw/v  ή=apparent viscosity w=shearing stress  v=rpm(shear rate) k=instrument constant
  • 30. Cone and plate viscometer  The sample is placed at the centre of the plate which is then raised into a position under the cone.  The cone is driven by a variable-speed motor and the sample is sheared in the narrow gap between the stationary plate and the rotating cone.  The rate of shear in rpm is increased or decreased by a selector dial and the viscous traction or torque(shear stress) produced on the cone is read on the indicator scale. ή=cT/v  c=instrument constant T=shearing stress  v=shear rate ή=viscosity
  • 31. Rheology  Rheology is the science that concerns with the flow of liquids and the deformation of solids.  Brookfield viscometer is used to evaluate the rheological properties and behaviour of settling of suspensions.  Brookfield viscometer mounted on helipath stand with T spindle.  The T bar rotates and descends slowly into the suspension with the help of synchronous motor.  The path traced by the spindle is a helix.As the T bar moves the sediment offers resistance.  The dial reading indicates the magnitude of resistance.  The dial reading is plotted against the number of turns of the spindle.  Good suspensions show a lesser rate of increase of dial reading as the spindle turns that is the curve is horizontal for a longer period.
  • 32.
  • 33. Zeta potential measurement  Zeta potential is defined as the difference in potential between the surface of the tightly bound layer(shear plane) and electro-neutral region of the solution.  Zeta potential has practical application in stability of systems containing dispersed particles since this potential governs the degree of repulsion between the adjacent similarly charged dispersed particles.  Value of zeta potential reflects the future stability of suspension so it is monitored time to time to ensure optimum zeta potential.  The flocculated suspension is one in which zeta potential of particle is -20 to +20 mv.
  • 34.  Zeta potential can be measured by  a)zeta meter  b)micro-electrophoresis  Electrophoresis  The principle of electrophoresis is used to determine the sign and magnitude of zeta potential.  Electrophoresis involves the movement of a charged particle through a liquid under the influence of an applied potential difference.  An electrophoresis cell is fitted with two electrodes.  The dispersion is introduced into the cell.when a potential is applied across the electrodes,particles migrate towards oppositely charged electrodes.  The rate of migration is a function of the charge on a particle.
  • 35.  As the potential gradient across the electrodes increases the velocity of migration of particles increases.  Velocity of migration potential gradient of particles (cm/sec) α across the electrodes v α E v=ζE There are number of factors that influence the migration so the zeta potential can be calculated by ζ = v4πή Eє
  • 36. Drug content uniformity  For proper dosing of the dosage form it is necessary that the active ingredient is uniformly distributed throughout the dosage form.so samples are withdrawn from the dispersed phase after micronization and after mixing with dispersion medium,assayed to find out degree of homogeneity.  If any discrepancy is found out it is suitably corrected by monitoring the mixing step to ensure a reliable dosage formulation.
  • 37. Particle size of dispersed phase  Optimum size of drug particle in the dispersed phase plays a vital role in stability of final suspension.  So this test is carried out to microscopically analyse and find out particle size range of drug then it is compared with optimum particle size required.  If any difference is found,stricter monitoring of micronization step is ensured.
  • 38. Particle size measurement  Particle size can be measured by  a)optical microscopy  b)sedimentation method  c)conductivity method(coulter counter method)
  • 39. Optical microscopy  Particle size in the range of 0.2 to 100μm can be measured by optical microscopy.  This method directly gives number distribution.  Method:Eye piece of the microscope is fitted with a micrometer.  The eye-piece micrometer is calibrated using a standard stage micrometer.  The sample of suspension is mounted on a slide or a ruled cell and placed it on the mechanical stage.  The size of the particle is estimated with the help of the eye-piece micrometer.  Around 625 particles must be counted in order to estimate the true mean.  The size frequency distribution curve is plotted by taking particle size in μm on x-axis and frequency on y-axis.
  • 40. Sedimentation method  Sedimentation method may be used over a size range of 1 to 200μm.  Sedimentation of particles are evaluated by  a)Andreasen pipette method  b)Balance method  c)Hydrometer method  In this methods the particle size is expressed as Stokes diameter.
  • 41. Andreasen pipette method  Andreasen apparatus consists of a 550 ml cylindrical vessel containing a 10 ml pipette sealed to a ground glass stopper.  When the pipette is placed in the cylinder its lower tip is 20 cm below the surface of the suspension.  Transfer the suspension into the Andreasen vessel and place the two-way pipette and securely suspend the vessel in a constant temperature water bath.  At different time intervals 10 ml of samples are withdrawn using two-way stopcock and collected in watch-glass,evaporated and weighed.  Particle diameter is calculated from stokes law.
  • 43. Sedimentation  An ideal suspension can be prepared by preventing the settling of particles.  The settling of particles can be explained by theories related to sedimentation. a)theory of Brownian movement b)theory of sedimentation  These theories provides information regarding factors that affect the settling of solids,these factors enable to take appropriate action in the manufacture of suspension.
  • 44. Theory of Brownian movement  Brownian movement of particles prevents sedimentation.  Brownian movement can be observed,if the size of the particle is about 2 to 5μm,provided densities of the particles and viscosity of the medium are favourable.  Theory of Brownian movement proposes particle size and viscosity as the major factors.
  • 45. Sedimentation rate  The rate of sedimentation of particles is expressed by Stokes law 2 d (Þ1-Þ2)g  rate of sedimentation= 18ή d=diameter of the particle(cm) Þ1=density of the dispersed phase(g/ml) Þ2=density of the dispersion medium(gm/ml) ή=viscosity of the dispersion medium(poise) g=acceleration due to gravity(980.7cm/sec)
  • 46.  Stokes law is useful in fixing factors to prevent sedimentation.  Particle size:If the particle size is reduced to half of itsoriginal size the rate of sedimentation decreases by a factor of four.  Viscosity of medium:The viscosity of suspension should be optimum.  Density of the medium:The density of medium should be high so that the difference in densities will be minimal.  The density of medium can be increased by including ingredients such as polyvinylpyrrolidine,sugars,polyethyleneglycols, glycerin etc.
  • 47. Sedimentation volume  It is the ratio between ultimate volume of sediment to initial volume of the suspension. F=Vu/V0=ultimate volume of the sediment initial volume of the suspension when a measuring cylinder is used to measure the volume it can be written as Hu/H0 The F value is between the limits 0 to 1. The higher the sedimentation volume the better is the physical stability.
  • 49. Redispersibility  If the particles settle they should be easily redispersible by a moderate amount of shaking.
  • 50. EMULSIONS  Emulsion systems consisting of at least two immiscible liquid phases,one of which is dispersed as small globules in the other liquid phase.  The globule diameter may range from 0.1 to 100 μm.  Emulsions are thermodynamically unstable systems.  Emulsions are also called as heterogeneous systems ,or more precisely biphasic systems.
  • 51. classification  1)Based on nature of dispersed phase a)oil-in-water(o/w) b)water-in-oil(w/o)  2)Based on the globule size a)micro emulsions(0.01μm) b)fine emulsions(0.25 to 25μm)
  • 53. Flocculation  Neighbouring globules come closer to each other and form colonies in the external phase.  This is the initial stage that leads to instability  The extent of flocculation of globules depends on  a)globule size distribution  b)charge on globule surface  c)viscosity of external medium
  • 54. Creaming  Creaming is the concentration of globules at the top or bottom of the emulsion.  The floccules move either upward or downward leading to creaming.  It can be observed by a difference in colour shade of the layers.  Creaming is influenced by  a)globule size  b)viscosity of the dispersion medium  c)differences in the densities of dispersed phase and dispersion medium
  • 55. Coalescence  Coalescence is followed by creaming stage.  In this process the emulsifier film around the globules is destroyed to a certain extent.  This step can be recognised by increased globule size and reduced number of globules.  Coalescence is observed due to a)insufficient amount of the emulsifying agent b)altered partitioning of the emulsifying agent c)incompatibilities between emulsifying agents
  • 56. Breaking  This is indicated by complete separation of oil and aqueous phases.  It is an irreversible process that is simple mixing fails to resuspend the globules into an uniform emulsion.  In breaking the protective sheath around the globules is completely destroyed.
  • 57. Phase inversion  This involves the change of emulsion type from o/w to w/o or vice versa.  When we intend to prepare one type of emulsion say o/w and if the final emulsion turns out to be w/o it can be termed as a sign of instability
  • 58. IPQC tests for emulsions  Appearance  Clarity testing  pH value  Viscosity  Rheology  Drug content uniformity  Particle size distribution  Densities of phases
  • 59.  Phase volume ratio  Charge of electrical double layer  Physical properties of interface  Temperature fluctuations  Quality control of water  Breaking or cracking  Compatibility of product with container-closure system
  • 60. viscosity  As the viscosity increases flocculation of globules will be reduced .simultaneously the Brownian movement of globules will also be hindered leading to creaming.  Due to this antagonistic effect an optimum viscosity is desirable for good stability.  Viscosity can be measured by  a)cop and bob viscometer  b)cone and plate viscometer
  • 61. Particle size  As the globule size is reduced they tend to exhibit Brownian movement.  According to stokes law the diameter of the globule is considered as a major factor in creaming of emulsion.The rate of creaming decreases four folds when the globule diameter is halved.  So it is necessary to choose the optimum globule size for maximum stability.
  • 62. Particle size distribution  Globules of uniform size impart maximum stability.  In such emulsions globules pack loosely and globule to globule contact is less.  Globule distribution is effected by viscosity,phase volume ratio,density of phases etc.  An optimum degree of size distribution range should be choosen to achieve maximum physical stability.
  • 63. Globule size determination  Microscopic examination of globule size distribution analysis is an useful tool to evaluate the physical stability.
  • 64. Phase volume ratio  In an emulsion the relative volume of water to oil is expressed as phase volume ratio.  In general most medicinal emulsions are prepared with a volume ratio of 50:50.This proportion brings about loose packing of globules.  The upper limit 74% of oil can be incorporated in an emulsion but this may lead to breaking of the emulsion.This value is referred to as critical point of phase volume ratio.  Critical point is defined as the concentration of internal phase above which the emulsifying agent cannot produce a stable emulsion of the desired type.
  • 65. Extent of phase separation .  The practical and commercial aspect of stability is the study of phase separation.  This is quick method and can be applied for poorly formed and rapidly breaking emulsions.  Separation of phases is visible after a definite period of time,though the signs of instability begin quite early.
  • 66. Charge of electrical double layer  When ionic type of emulsifier is employed, the electrical double layer(interface between oil and water)possesses charge.  The repulsive forces,due to like charges on the surface of the globules prevent the flocculation of globules.
  • 67. Physical properties of interface  The interfacial film of the emulsifier is responsible for enhancing the stability of the product.  The film should be elastic enough to form rapidly as soon as droplets are produced.This behaviour facilitates the production of emulsion.  Similarly on moderate shaking the emulsion should be reconstituted.  After manufacture the film should be tough so that coalescence of globules can be prevented.  So suitable emulsifying agents such as surfactants should be selected to achieve the above film properties at the interface.
  • 68. Densities of phases  By adjusting the density of the phases to the same value we can increase the stability of emulsion.  Oil phase density can be enhanced by adding brominated oil when the oil is an external phase.
  • 69. Temperature fluctuations  Elevated temperatures alter the partition characteristics of the emulsifiers and preservatives results in instability.  Temperature also enhances the chemical degradation of drugs and other ingredients.  At lower temperature the aqueous phase may contain ice crystals which rupture the interfacial film and break the emulsion.  So care should be taken to prevent temperature fluctuations during manufacture and storage.
  • 70. Phase inversion  The emulsion is checked for phase inversion.  Phase inversion means a change of emulsion type from o/w to w/o or vice versa.
  • 71. Completion stage  At the completion of manufacturing process as well as in-process stages,actual yields are checked against theoretic value and the repre sentative sample are withdrawn for laboratory testing by the control inspector according to the predetermined sampling plan.
  • 72. Record and report  The batch production records and other needed documents are then delivered to the quality control office together with the withdrawn samples of the products.
  • 73. Packaging material control  Packaging material should not interact physically or chemically with the finished product to alter the strength,quality or purity beyond specified requirements.  The following features are to be considered in developing container specifications  Properties of container tightness  Moisture and vapour tightness regardless of container construction  Compatibility between container and product
  • 74.  Toxicity and chemical/physical characteristics of materials needed in container construction.  Physical or chemical changes of container upon prolonged contact with product.
  • 75. Labels control  Production control issues a packaging form that carries  The name of the product  Item number  Lot number  Number of labels  Inserts  Packaging material to be used  Operation to be performed  Quantity to be packaged  A copy of this is sent to the supervisor of label control,who in turn counts out the required number of labels.
  • 76. conclusion  IPQC tests are carried out during the manufacturing to ensure stable,safe and quality product.
  • 77. References  Lachman L,Lieberman H,The Theory and Practice of Industrial pharmacy;3rd edition,page number-810 to 835.  C.V.S.Subrahmanyam,Text book of Physical Pharmaceutics,page number-195 to 203,366 to 423.  Encyclopedia volume-6 page number 3105- 3107.